These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23015581)

  • 1. Pharmacotherapy for posttraumatic stress disorder: review with clinical applications.
    Jeffreys M; Capehart B; Friedman MJ
    J Rehabil Res Dev; 2012; 49(5):703-15. PubMed ID: 23015581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in prescribing among veterans diagnosed with posttraumatic stress disorder.
    Bernardy NC; Lund BC; Alexander B; Jenkyn AB; Schnurr PP; Friedman MJ
    J Gen Intern Med; 2013 Jul; 28 Suppl 2(Suppl 2):S542-8. PubMed ID: 23807063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance between psychotropic prescribing for veterans with PTSD and clinical practice guidelines.
    Jain S; Greenbaum MA; Rosen C
    Psychiatr Serv; 2012 Feb; 63(2):154-60. PubMed ID: 22302333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type.
    Abrams TE; Lund BC; Bernardy NC; Friedman MJ
    Psychiatr Serv; 2013 Feb; 64(2):142-8. PubMed ID: 23474508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacological treatment in PTSD: a critical review.
    Albucher RC; Liberzon I
    J Psychiatr Res; 2002; 36(6):355-67. PubMed ID: 12393304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Medication Prescribing in Patients With PTSD From 2009 to 2018: A National Veterans Administration Study.
    Holder N; Woods A; Neylan TC; Maguen S; Seal KH; Bernardy N; Wiechers I; Ryder A; Urbieta AM; Cohen BE
    J Clin Psychiatry; 2021 May; 82(3):. PubMed ID: 34004087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing trends in veterans with posttraumatic stress disorder.
    Bernardy NC; Lund BC; Alexander B; Friedman MJ
    J Clin Psychiatry; 2012 Mar; 73(3):297-303. PubMed ID: 22490256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection.
    Mohamed S; Rosenheck RA
    J Clin Psychiatry; 2008 Jun; 69(6):959-65. PubMed ID: 18588361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for posttraumatic stress disorder at a Veterans Affairs facility.
    Kobayashi TM; Patel M; Lotito M
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S11-5. PubMed ID: 25991587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: managing posttraumatic stress disorder in combat veterans with comorbid traumatic brain injury.
    Capehart B; Bass D
    J Rehabil Res Dev; 2012; 49(5):789-812. PubMed ID: 23015586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for older veterans diagnosed with posttraumatic stress disorder in Veterans Administration.
    Mohamed S; Rosenheck R
    Am J Geriatr Psychiatry; 2008 Oct; 16(10):804-12. PubMed ID: 18827226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTSD and substance use disorder among veterans: characteristics, service utilization and pharmacotherapy.
    Bowe A; Rosenheck R
    J Dual Diagn; 2015; 11(1):22-32. PubMed ID: 25513763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographical diffusion of prazosin across Veterans Health Administration: Examination of regional variation in daily dosing and quality indicators among veterans with posttraumatic stress disorder.
    Abrams TE; Lund BC; Alexander B; Bernardy NC; Friedman MJ
    J Rehabil Res Dev; 2015; 52(5):619-27. PubMed ID: 26437180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of prazosin for the treatment of posttraumatic stress disorder nightmares in U.S. military veterans.
    Breen A; Blankley K; Fine J
    J Am Assoc Nurse Pract; 2017 Feb; 29(2):65-69. PubMed ID: 27977074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mental health outcomes of augmenting medications for patients with posttraumatic stress disorder: A national veterans affairs study.
    Ranney R; Maguen S; Woods A; Seal KH; Neylan TC; Bernardy N; Wiechers I; Ryder A; Cohen BE
    J Eval Clin Pract; 2023 Feb; 29(1):191-202. PubMed ID: 35709244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cultivating change door to door: Educational outreach to improve prescribing practices in rural veterans with posttraumatic stress disorder.
    Montaño M; Bernardy NC; Sherrieb K
    Subst Abus; 2017; 38(2):129-134. PubMed ID: 28277828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracing the flow of knowledge: geographic variability in the diffusion of prazosin use for the treatment of posttraumatic stress disorder nationally in the Department of Veterans Affairs.
    Harpaz-Rotem I; Rosenheck RA
    Arch Gen Psychiatry; 2009 Apr; 66(4):417-21. PubMed ID: 19349311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment and treatment of posttraumatic anger and aggression: a review.
    Taft CT; Creech SK; Kachadourian L
    J Rehabil Res Dev; 2012; 49(5):777-88. PubMed ID: 23015585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial.
    Fortney JC; Pyne JM; Kimbrell TA; Hudson TJ; Robinson DE; Schneider R; Moore WM; Custer PJ; Grubbs KM; Schnurr PP
    JAMA Psychiatry; 2015 Jan; 72(1):58-67. PubMed ID: 25409287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of posttraumatic stress disorder: diagnostic and therapeutic issues.
    Davidson JR; Connor KM
    J Clin Psychiatry; 1999; 60 Suppl 18():33-8. PubMed ID: 10487254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.